James Mortensen joined the board on 1 November 2023
and was appointed as Chief Financial Officer on 1 January 2024.
James has a proven track record in industrial, engineering and technology sectors and extensive experience building and managing global, multi-disciplinary finance teams. He joins Chemring from Smiths Group plc, the FTSE 100 engineering group, where he held a number of senior roles including Group Head of Corporate Development and Chief Financial Officer of Smiths Medical. Prior to joining Smiths, James spent eight years at Smith & Nephew plc, where he held various senior finance roles. James started his career in KPMG's audit practice.